fluphenazine has been researched along with flupenthixol in 90 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 70 (77.78) | 18.7374 |
1990's | 8 (8.89) | 18.2507 |
2000's | 6 (6.67) | 29.6817 |
2010's | 4 (4.44) | 24.3611 |
2020's | 2 (2.22) | 2.80 |
Authors | Studies |
---|---|
Gründig, E; Weiss, J | 1 |
Dencker, SJ | 1 |
Hyttel, J | 2 |
Munday, KA; Poat, JA; Sumners, C; Woodruff, GN | 1 |
Barnes, JL; Mee, TJ; Smith, JA | 1 |
Poat, JA; Watling, KJ; Woodruff, GN | 1 |
Goude, F; Lanza, JP; Lanza, M | 1 |
Card, IR; Hamilton, M; Mahmoud, MR; Wallis, GG | 1 |
Freedman, R; Hoffer, BJ | 1 |
Palatini, P | 1 |
Iversen, LL; Jessell, TM; Reubi, JC | 1 |
Arató, M; Erdós, A | 1 |
Bannerjee, A; Ghosh, N; Pinto, R | 1 |
Hirsch, SR; Knights, A; Okasha, MS; Salih, MA | 1 |
Banning, B; Freeman, HL; Kelly, HB; Schiff, AA | 1 |
Breen, M; Johnson, DA | 1 |
Blake, B | 1 |
Freeman, H | 1 |
Hui, SM; Paxton, JW; Rowell, FJ | 1 |
Johnson, DA | 3 |
Frithz, A | 1 |
Freedman, R | 1 |
Börger, J; Nolen, WA | 1 |
Gibson, AC | 2 |
Angst, J; Margoses, N; Woggon, B | 1 |
Floru, L; Heinrich, K; Wittek, F | 1 |
Baudis, P; Dvoráková, M; Peterová, E; Vencovský, E | 1 |
Cook, AR | 1 |
Carney, MW; Sheffield, BF | 1 |
Johnson, DA; Malik, NA | 1 |
Whitehead, T | 1 |
Haffmans, PJ; Hoencamp, E; Jansen, GS | 1 |
Krska, J; Sampath, G; Shah, A; Soni, SD | 1 |
Kehoe, R; Young, A | 1 |
Kong, DS; Yeo, SH | 2 |
Ardern, M; Gelder, MG; Jambor, K; Kolakowska, T; Mandelbrote, BM; Reveley, MA; Williams, AO | 1 |
Ardern, M; Kolakowska, T; Williams, AO | 1 |
Knudsen, P | 1 |
Beart, PM; Cincotta, M; de Vries, DJ | 1 |
Jauregui, J; Kelley, AE; Nadaud, D; Stinus, L | 1 |
Ardern, M; Kolakowska, T; Reveley, MA; Williams, AO | 1 |
Dinan, TG | 1 |
Bartkó, G; Herczeg, I; Zádor, G | 1 |
Goodall, E; Silverstone, T; Smith, G | 1 |
Hunter, L; Turbott, J; Villiger, J | 2 |
Daw, NW; Jensen, RJ | 2 |
Nielsen, IM | 1 |
Kolakowska, T; Wiles, D; Wistedt, B | 1 |
Freedman, R; Geller, HM; Hoffer, BJ; Marwaha, J | 1 |
Blake, IM; Braddock, LE | 1 |
Coufal, J; Novotný, M | 1 |
Bartels, M; Riffel, B; Stöhr, M | 1 |
Johnson, DA; Ludlow, JM; Pasterski, G; Street, K; Taylor, RD | 1 |
Berkowitz, R; Eberlein-Fries, R; Kuipers, L; Leff, J; Sturgeon, D | 1 |
Hansen, V; Jorgensen, A; Mackie, M; McCreadie, RG; Menzies, C; Wiles, DH | 1 |
Ranta, J; Wistedt, B | 1 |
Hertrich, O | 1 |
Palmstierna, T; Wistedt, B | 1 |
Jørgensen, A; Wiles, D; Wistedt, B | 1 |
Eccleston, D; Fairbairn, AF; Hassanyeh, F; Hui, SM; Robinson, AJ; Rowell, FJ | 1 |
Conway, JF | 1 |
Wistedt, B | 1 |
Kamlana, SH; Kerry, RJ; Khan, IA | 1 |
Naylor, GJ; Scott, CR | 1 |
Barnes, TR; Bridges, PK | 1 |
Chuang, YC; Huang, WT; Lin, MT; Liu, HS; Won, SJ | 1 |
Ganguli, R; Nimgaonkar, VL; Silver, MA; Yang, ZW | 1 |
Bindl, A; Eberlein-König, B; Przybilla, B | 1 |
Hait, WN; LaVoie, EJ; Makhey, DB; Sullivan, GF; Yang, JM | 1 |
Al-Sughayir, MA | 1 |
Allahham, A; Mainwaring, DE; Marriott, J; Stewart, P | 1 |
Eerdekens, E; Eerdekens, M; Jacko, M; Turner, M | 1 |
Broll, K; Hess, L; Ibach, B; Perfahl, M; Pfeiff, L; Putzhammer, A | 1 |
Dembler, T; Gallinat, J; Heinz, A; Juckel, G; Kahnt, T; Kienast, T; Knutson, B; Koslowski, M; Schlagenhauf, F; Wrase, J | 1 |
Chen, YC; Chen, YW; Chu, CC; Leung, YM; Wang, JJ | 1 |
Gowda, R; Kuzu, OF; Noory, MA; Robertson, GP | 1 |
Barbui, C; Bertolini, F; Bovo, C; Correll, CU; Del Giovane, C; Gastaldon, C; Nosé, M; Ogheri, F; Ostuzzi, G; Papola, D; Purgato, M; Tedeschi, F; Turrini, G | 1 |
Osman, E; Yıldız, M | 1 |
George, SR; Guan, HC; Laurier, LG; Ng, G; Niznik, HB; O'Dowd, BF; Seeman, P; Sunahara, RK; Torchia, J; Van Tol, HH | 1 |
Pajeva, I; Wiese, M | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Brincat, JP; Carosati, E; Cruciani, G; Fravolini, A; Kaatz, GW; Manfroni, G; Patel, D; Raygada, JL; Sabatini, S | 1 |
Bennis, K; Ducki, S; Lesage, F; Vivier, D | 1 |
3 review(s) available for fluphenazine and flupenthixol
Article | Year |
---|---|
[Current status of neuroleptic long term treatment of schizophrenia].
Topics: Ambulatory Care; Antiparkinson Agents; Chronic Disease; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Fluspirilene; Humans; Long-Term Care; Penfluridol; Placebos; Prognosis; Recurrence; Schizophrenia; Tranquilizing Agents | 1975 |
Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis.
Topics: Antipsychotic Agents; Aripiprazole; Clopenthixol; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Patient Acceptance of Health Care; Phenothiazines; Psychotic Disorders; Risperidone; Schizophrenia; Secondary Prevention | 2021 |
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?
Topics: Arrhythmias, Cardiac; Depression; Epilepsy; Humans; Inflammation; Models, Molecular; Molecular Structure; Neuroprotective Agents; Pain; Potassium Channels, Tandem Pore Domain; Structure-Activity Relationship | 2016 |
17 trial(s) available for fluphenazine and flupenthixol
Article | Year |
---|---|
A comparative trial of the decanoates of flupenthixol and fluphenazine.
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Decanoates; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Thioxanthenes | 1979 |
[Experience with depot neuroleptics].
Topics: Adolescent; Adult; Clinical Trials as Topic; Delayed-Action Preparations; Drug Evaluation; Drug Therapy, Combination; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Recurrence; Schizophrenia; Thioxanthenes | 1979 |
A double-blind comparison of flupenthixol decanoate and fluphenazine decanoate in the treatment of chronic schizophrenia.
Topics: Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Flupenthixol; Fluphenazine; Humans; Psychiatric Status Rating Scales; Random Allocation; Schizophrenia; Thioxanthenes | 1979 |
Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients.
Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Clinical Trials as Topic; Depression; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Social Adjustment; Thioxanthenes | 1979 |
Disturbances of liver function of long acting neuroleptic drugs.
Topics: Adolescent; Adult; Aged; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Flupenthixol; Fluphenazine; Fluspirilene; Humans; Liver; Liver Function Tests; Male; Mental Disorders; Middle Aged; Spiro Compounds; Thioxanthenes | 1978 |
The problem of post-psychotic schizophrenic depressions and their pharmacological induction. Long-term studies with fluspirilene and penfluridol and single-blind trial with fluphenazine-decanoate and flupenthixol-decanoate.
Topics: Adult; Antidepressive Agents; Clinical Trials as Topic; Depression; Female; Flupenthixol; Fluphenazine; Fluspirilene; Humans; Long-Term Care; Male; Penfluridol; Personality Inventory; Piperidines; Schizophrenia; Spiro Compounds; Thioxanthenes | 1975 |
A double-blind comparison of fluphenazine decanoate and flupenthixol decanoate in the treatment of acute schizophrenia.
Topics: Acute Disease; Chlorpromazine; Clinical Trials as Topic; Drug Evaluation; Flupenthixol; Fluphenazine; Humans; Placebos; Schizophrenia; Time Factors | 1975 |
An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
Topics: Clinical Trials as Topic; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Thioxanthenes; Tranquilizing Agents | 1989 |
Psychosocial relevance and benefit of neuroleptic maintenance: experience in the United Kingdom.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Attitude to Health; Clinical Trials as Topic; Delayed-Action Preparations; Family; Family Therapy; Female; Flupenthixol; Fluphenazine; Follow-Up Studies; Health Education; Humans; Interview, Psychological; Life Change Events; Male; Middle Aged; Outcome and Process Assessment, Health Care; Psychotherapy, Group; Recurrence; Schizophrenia; Schizophrenic Psychology; Stress, Psychological; United Kingdom | 1984 |
Comparative double-blind study of flupenthixol decanoate and fluphenazine decanoate in the treatment of patients relapsing in a schizophrenic symptomatology.
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Depression; Double-Blind Method; Flupenthixol; Fluphenazine; Humans; Middle Aged; Random Allocation; Recurrence; Schizophrenia; Thioxanthenes; Time Factors | 1983 |
Depressive symptoms in chronic schizophrenic patients after withdrawal of long-acting neuroleptics.
Topics: Adult; Depressive Disorder; Double-Blind Method; Female; Flupenthixol; Fluphenazine; Humans; Male; Psychiatric Status Rating Scales; Random Allocation; Recurrence; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome; Thioxanthenes; Tranquilizing Agents | 1983 |
A depot neuroleptic withdrawal study. Plasma concentration of fluphenazine and flupenthixol and relapse frequency.
Topics: Delayed-Action Preparations; Female; Flupenthixol; Fluphenazine; Humans; Male; Recurrence; Schizophrenia; Substance Withdrawal Syndrome; Thioxanthenes; Time Factors | 1982 |
Flupenthixol versus combined fluphenazine-nortriptyline in depressive illness.
Topics: Adult; Aged; Clinical Trials as Topic; Depression; Drug Combinations; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Nortriptyline; Thioxanthenes | 1981 |
Studies of depressive symptoms in schizophrenia.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Flupenthixol; Fluphenazine; Humans; Longitudinal Studies; Male; Middle Aged; Nortriptyline; Orphenadrine; Schizophrenia; Schizophrenic Psychology | 1981 |
A depot neuroleptic withdrawal study. A controlled study of the clinical effects of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients.
Topics: Adult; Aged; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Placebos; Recurrence; Schizophrenia; Substance Withdrawal Syndrome; Thioxanthenes | 1981 |
Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics.
Topics: Adult; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Movement Disorders; Psychiatric Status Rating Scales; Risperidone; Schizophrenia | 2004 |
[Alterations of gait parameters under external cueing in schizophrenic patients: a switch study].
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dose-Response Relationship, Drug; Exercise Test; Female; Flupenthixol; Fluphenazine; Gait; Haloperidol; Humans; Male; Middle Aged; Muscle Rigidity; Olanzapine; Schizophrenia | 2004 |
70 other study(ies) available for fluphenazine and flupenthixol
Article | Year |
---|---|
[The influence of neuroleptic drugs on urinary excretion of non-protein nitrogen (author's transl)].
Topics: Amino Acids; Clopenthixol; Clozapine; Creatinine; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Humans; Hydrogen-Ion Concentration; Ion Exchange Resins; Nitrogen; Procyclidine; Schizophrenia; Thioridazine; Tranquilizing Agents; Urea | 1976 |
High-dose treatment with neuroleptics in the acute phase of mental disease.
Topics: Antipsychotic Agents; Flupenthixol; Fluphenazine; Haloperidol; Humans; Mental Disorders; Perphenazine; Time Factors | 1976 |
Changes in dopamine synthesis rate in the supersensitivity phase after treatment with a single dose of neuroleptics.
Topics: Animals; Antipsychotic Agents; Brain; Dopamine; Flupenthixol; Fluphenazine; Haloperidol; Male; Mice; Receptors, Dopamine; Time Factors | 1977 |
The effect of neuroleptic drugs on drinking induced by central administration of angiotensin or carbachol.
Topics: Angiotensin II; Animals; Antipsychotic Agents; Carbachol; Chlorpromazine; Clozapine; Dopamine; Drinking Behavior; Flupenthixol; Fluphenazine; Haloperidol; Injections, Intraperitoneal; Injections, Intraventricular; Male; Pimozide; Rats; Sulpiride | 1979 |
The effect of neuroleptic drugs on serum and cerebrospinal fluid melatonin concentrations in psychiatric subjects.
Topics: Adolescent; Adult; Age Factors; Aged; Antipsychotic Agents; Chlorpromazine; Female; Flupenthixol; Fluphenazine; Humans; Male; Melatonin; Mental Disorders; Middle Aged | 1979 |
Dopamine-sensitive adenylate cyclase in homogenates of rat nucleus accumbens: structure-activity studies and effects of agonists and antagonists.
Topics: Adenylyl Cyclases; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Animals; Apomorphine; Dopamine; Dopamine Antagonists; Flupenthixol; Fluphenazine; Male; Nucleus Accumbens; Phenethylamines; Phentolamine; Propranolol; Rats; Receptors, Dopamine; Salsoline Alkaloids; Septal Nuclei; Structure-Activity Relationship | 1979 |
Neurochemical parameters in the hyperresponsive phase after a single dose of neuroleptics to mice.
Topics: Animals; Antipsychotic Agents; Binding, Competitive; Brain; Cell Membrane; Flupenthixol; Fluphenazine; Haloperidol; Kinetics; Male; Mice; Piperazines; Receptors, Drug; Thioxanthenes; Tissue Distribution | 1979 |
[Effect of a single dose of some long-acting neuroleptics on the estrus cycle and the mammary gland of the rat].
Topics: Animals; Antipsychotic Agents; Caproates; Estrus; Female; Flupenthixol; Fluphenazine; Mammary Glands, Animal; Organ Size; Ovary; Phenothiazines; Pregnancy; Pseudopregnancy; Rats; Thiazines; Uterus | 1979 |
Phenothiazine antagonism of the noradrenergic inhibition of cerebellar Purkinje neurons.
Topics: Animals; Cerebral Ventricles; Cyclic AMP; Flupenthixol; Fluphenazine; GABA Antagonists; Iontophoresis; Isomerism; Male; Neural Inhibition; Neural Pathways; Norepinephrine; Purkinje Cells; Rats; Thioxanthenes; Time Factors | 1975 |
Mechanism of inhibition of sodium- and potassium-dependent adenosine triphosphatase by tricyclic antipsychotics.
Topics: 4-Nitrophenylphosphatase; Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Brain; Drug Interactions; Flupenthixol; Fluphenazine; Free Radicals; Guinea Pigs; In Vitro Techniques; Kinetics; Magnesium; Microsomes; Phosphorus Radioisotopes; Potassium; Sodium; Spectrophotometry; Thioxanthenes | 1977 |
Dopamine selectively increases 3H-GABA release from slices of rat substantia nigra in vitro.
Topics: Aminobutyrates; Animals; Bucladesine; Calcium; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Flupenthixol; Fluphenazine; gamma-Aminobutyric Acid; In Vitro Techniques; Potassium Chloride; Rats; Receptors, Dopamine; Substance P; Substantia Nigra | 1977 |
Clinical and social comparison of fluphenazine decanoate and flupenthixol decanoate in the community maintenance therapy of schizophrenia.
Topics: Adolescent; Adult; Chronic Disease; Community Mental Health Services; Female; Flupenthixol; Fluphenazine; Humans; Long-Term Care; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Social Adjustment; Thioxanthenes | 1977 |
Weight changes with depot neuroleptic maintenance therapy.
Topics: Body Weight; Decanoates; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Humans; Prospective Studies; Schizophrenia; Time Factors | 1979 |
Depot neuroleptics in a community mental health service.
Topics: Clopenthixol; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Humans; Psychotic Disorders; Thioxanthenes | 1979 |
Pimozide as a neuroleptic.
Topics: Delusions; Dyskinesia, Drug-Induced; Flupenthixol; Fluphenazine; Humans; Pimozide; Schizophrenia | 1979 |
The evaluation of a radioimmunoassay for phenothiazines and thioxanthenes using an iodinated tracer.
Topics: Animals; Antibody Specificity; Binding Sites, Antibody; Cross Reactions; Flupenthixol; Fluphenazine; Humans; Iodine Radioisotopes; Phenothiazines; Rabbits; Radioimmunoassay; Thioxanthenes; Trifluoperazine | 1979 |
Further observations on the duration of depot neuroleptic maintenance therapy in schizophrenia.
Topics: Delayed-Action Preparations; Flupenthixol; Fluphenazine; Humans; Recurrence; Schizophrenia; Thioxanthenes | 1979 |
Delusions of infestation: treatment by depot injections of neuroleptics.
Topics: Adult; Aged; Antiparasitic Agents; Delayed-Action Preparations; Delusions; Female; Flupenthixol; Fluphenazine; Humans; Hypochondriasis; Injections; Male; Middle Aged; Thioxanthenes | 1979 |
Interactions of antipsychotic drugs with norepinephrine and cerebellar neuronal circuitry: implications for the psychobiology of psychosis.
Topics: Action Potentials; Afferent Pathways; Animals; Cerebellum; Dose-Response Relationship, Drug; Drug Antagonism; Drug Interactions; Flupenthixol; Fluphenazine; Humans; Isomerism; Male; Models, Neurological; Neural Inhibition; Neurons; Norepinephrine; Promethazine; Psychotic Disorders; Purkinje Cells; Rats | 1977 |
Depot injections and tardive dyskinesia.
Topics: Chorea; Delayed-Action Preparations; Dyskinesia, Drug-Induced; Female; Flupenthixol; Fluphenazine; Humans; Injections; Male; Middle Aged; Prospective Studies; Schizophrenia; Thioxanthenes | 1978 |
[Clinical experiences with depot neuroleptics].
Topics: Delayed-Action Preparations; Depressive Disorder, Major; Female; Flupenthixol; Fluphenazine; Humans; Male; Psychotic Disorders; Schizophrenia; Thioxanthenes | 1975 |
Psychotropic drugs in depot form.
Topics: Amitriptyline; Depression; Flupenthixol; Fluphenazine; Humans; Injections, Intravenous | 1976 |
Comparison of antipsychotic depot injections in the maintenance treatment of schizophrenia.
Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Delayed-Action Preparations; Depression; Female; Flupenthixol; Fluphenazine; Humans; Injections, Intramuscular; Male; Middle Aged; Mortality; Patient Compliance; Patient Readmission; Schizophrenia; Thioxanthenes; Time Factors | 1976 |
Letter: long-acting phenothiazines.
Topics: Aged; Delayed-Action Preparations; Female; Flupenthixol; Fluphenazine; Humans; Middle Aged; Paranoid Disorders; Phenothiazines | 1975 |
Lowest effective dose of depot neuroleptics.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology | 1992 |
Rationalizing neuroleptic polypharmacy in chronic schizophrenics: effects of changing to a single depot preparation.
Topics: Administration, Oral; Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Flupenthixol; Fluphenazine; Humans; Injections, Intramuscular; Male; Middle Aged; Neurologic Examination; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Schizophrenic Psychology | 1992 |
Two cases of agranulocytosis on addition of a butyrophenone to a long-standing course of phenothiazine treatment.
Topics: Agranulocytosis; Antipsychotic Agents; Chlorpromazine; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Droperidol; Drug Therapy, Combination; Female; Flupenthixol; Fluphenazine; Humans; Long-Term Care; Male; Middle Aged; Paranoid Disorders; Psychotic Disorders | 1989 |
Schizophrenia with good and poor outcome. I: Early clinical features, response to neuroleptics and signs of organic dysfunction.
Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Brain; Chlorpromazine; Cognition Disorders; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Prognosis; Prolactin; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Tomography, X-Ray Computed | 1985 |
Tardive dyskinesia and current dose of neuroleptic drugs.
Topics: Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Flupenthixol; Fluphenazine; Humans; Middle Aged; Psychotic Disorders; Schizophrenia | 1985 |
Chemotherapy with neuroleptics. Clinical and pharmacokinetic aspects with a particular view to depot preparations.
Topics: Administration, Oral; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Flupenthixol; Fluphenazine; Haloperidol; Humans; Kinetics; Long-Term Care; Patient Compliance; Perphenazine; Schizophrenia; Schizophrenic Psychology; Thiazines | 1985 |
Characteristics of D-1 dopamine receptors labelled by [3H]fluphenazine in homogenates of rat neostriatum.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Binding, Competitive; Clopenthixol; Corpus Striatum; Female; Fenoldopam; Flupenthixol; Fluphenazine; In Vitro Techniques; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1 | 1985 |
Chronic treatment with five different neuroleptics elicits behavioral supersensitivity to opiate infusion into the nucleus accumbens.
Topics: Animals; Antipsychotic Agents; Enkephalin, Methionine; Flupenthixol; Fluphenazine; Haloperidol; Male; Nucleus Accumbens; Perphenazine; Phenothiazines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine; Septal Nuclei; Sulpiride; Time Factors | 1986 |
Tardive dyskinesia in schizophrenics under 60 years of age.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Flupenthixol; Fluphenazine; Humans; Male; Prognosis; Schizophrenia | 1986 |
Neuroleptic effects on platelet aggregation: a study in normal volunteers and schizophrenics.
Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Haloperidol; Humans; Male; Platelet Aggregation; Procyclidine; Schizophrenia; Sulpiride; Trifluoperazine | 1987 |
Clinical symptomatology and drug compliance in schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Female; Flupenthixol; Fluphenazine; Fluspirilene; Humans; Male; Middle Aged; Patient Compliance; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1988 |
Prevalence of obesity in patients receiving depot antipsychotics.
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Female; Flupenthixol; Fluphenazine; Humans; Male; Obesity; Schizophrenia; Social Class | 1988 |
The significance of depression in the prediction of relapse in chronic schizophrenia.
Topics: Adult; Depressive Disorder; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Recurrence; Risk Factors; Schizophrenia; Schizophrenic Psychology; Time Factors | 1988 |
Depot neuroleptic medication and serum levels by radioreceptor assay: prolactin concentration, electrocardiogram abnormalities and six-month outcome.
Topics: Adult; Delayed-Action Preparations; Dose-Response Relationship, Drug; Electrocardiography; Female; Flupenthixol; Fluphenazine; Heart; Humans; Male; Middle Aged; Prolactin; Radioligand Assay; Schizophrenia; Thioxanthenes | 1987 |
Effects of dopamine and its agonists and antagonists on the receptive field properties of ganglion cells in the rabbit retina.
Topics: Action Potentials; Animals; Apomorphine; Dopamine; Dopamine Antagonists; Flupenthixol; Fluphenazine; Haloperidol; Photic Stimulation; Rabbits; Reaction Time; Receptors, Dopamine; Retina; Retinal Ganglion Cells; Sulpiride; Visual Fields | 1986 |
Flupenthixol decanoate and fluphenazine decanoate in chronic schizophrenia.
Topics: Adult; Chronic Disease; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Schizophrenia; Thioxanthenes | 1985 |
Neuroleptic serum levels measured by radioreceptor assay in patients receiving intramuscular depot neuroleptics. Some preliminary findings.
Topics: Adult; Delayed-Action Preparations; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Schizophrenia; Thioxanthenes | 1985 |
Pharmacological vs. clinical physiognomy of neuroleptics, with special reference to their sedative and antipsychotic effects.
Topics: Animals; Behavior, Animal; Chlorpromazine; Chlorprothixene; Clopenthixol; Dogs; Drug Evaluation, Preclinical; Drug Tolerance; Flupenthixol; Fluphenazine; Haloperidol; Mice; Motor Activity; Perphenazine; Rats; Tranquilizing Agents | 1974 |
Slow decline of plasma drug and prolactin levels after discontinuation of chronic treatment with depot neuroleptics.
Topics: Delayed-Action Preparations; Female; Flupenthixol; Fluphenazine; Half-Life; Humans; Prolactin; Thioxanthenes | 1981 |
Electrophysiologic interactions of antipsychotic drugs with central noradrenergic pathways.
Topics: Animals; Antipsychotic Agents; Dose-Response Relationship, Drug; Flupenthixol; Fluphenazine; Haloperidol; Male; Neural Pathways; Norepinephrine; Purkinje Cells; Rats | 1981 |
Incidence of tardive dyskinesia in patients receiving depot neuroleptic injection.
Topics: Antipsychotic Agents; Delayed-Action Preparations; Dyskinesia, Drug-Induced; Female; Flupenthixol; Fluphenazine; Fluspirilene; Humans; Male; Middle Aged | 1981 |
Neuroendocrine tests during treatment with neuroleptic drugs. II. The TRH test.
Topics: Adult; Aged; Antipsychotic Agents; Delayed-Action Preparations; Female; Flupenthixol; Fluphenazine; Growth Hormone; Haloperidol; Humans; Male; Middle Aged; Pituitary Function Tests; Prolactin; Schizophrenia; Stimulation, Chemical; Thyrotropin-Releasing Hormone | 1981 |
Fluphenazine and flupenthixol decanoate in psychiatric outpatients practice.
Topics: Adult; Antipsychotic Agents; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Schizophrenia; Thioxanthenes | 1981 |
[Tardive dystonia: a rare side effect after long-term neuroleptic treatment].
Topics: Adult; Antipsychotic Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Flupenthixol; Fluphenazine; Humans; Long-Term Care; Male; Schizophrenia, Paranoid; Torticollis | 1982 |
The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients: drug and social consequences.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Drug Administration Schedule; Female; Flupenthixol; Fluphenazine; Humans; Male; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Schizophrenic Psychology; Social Adjustment; Thioxanthenes | 1983 |
Within-individual variation in steady state plasma levels of different neuroleptics and prolactin.
Topics: Administration, Oral; Adult; Aged; Antipsychotic Agents; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Kinetics; Male; Middle Aged; Pimozide; Prolactin; Schizophrenia | 1984 |
Effects of dopamine antagonists on receptive fields of brisk cells and directionally selective cells in the rabbit retina.
Topics: Animals; Dopamine Antagonists; Flupenthixol; Fluphenazine; Haloperidol; Metoclopramide; Rabbits; Receptors, Dopamine; Retina; Retinal Ganglion Cells; Sulpiride | 1984 |
[Ataractic treatment in psychiatry and general medicine. Overview of preparations 6].
Topics: Flunitrazepam; Flupenthixol; Fluphenazine; Flurazepam; Fluspirilene; Humans; Tranquilizing Agents | 1983 |
Serum concentration of depot neuroleptics in tardive dyskinesia.
Topics: Dyskinesia, Drug-Induced; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Schizophrenia; Thioxanthenes | 1983 |
Lithium: some drug interactions.
Topics: Adult; Drug Interactions; Drug Therapy, Combination; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Lithium; Male; Middle Aged | 1980 |
Depot injections for affective disorders.
Topics: Adolescent; Aged; Bipolar Disorder; Delayed-Action Preparations; Female; Flupenthixol; Fluphenazine; Humans; Middle Aged; Thioxanthenes | 1980 |
Disturbed behavior induced by high-dose antipsychotic drugs.
Topics: Adult; Aggression; Drug Administration Schedule; Female; Flupenthixol; Fluphenazine; Humans; Male; Schizophrenia; Thioxanthenes | 1980 |
Suppression of natural killer cell activity in mouse spleen lymphocytes by several dopamine receptor antagonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Cytotoxicity, Immunologic; Dopamine Antagonists; Flupenthixol; Fluphenazine; Killer Cells, Natural; Mice; Mice, Inbred C3H; Pimozide; Spiperone; Spleen; Thiothixene; Trifluoperazine | 1995 |
An inhibitory effect of psychoactive drugs on a human neuroblastoma cell line.
Topics: Antipsychotic Agents; Cell Division; Cell Line; Dose-Response Relationship, Drug; Flupenthixol; Fluphenazine; Haloperidol; Humans; Neuroblastoma; Tumor Cells, Cultured | 1994 |
Phototoxic properties of neuroleptic drugs.
Topics: Antipsychotic Agents; Chlorpromazine; Chlorprothixene; Clopenthixol; Dermatitis, Phototoxic; Drug Eruptions; Erythrocytes; Flupenthixol; Fluphenazine; Hemolysis; Humans; Methotrimeprazine; Perazine; Perphenazine; Phenothiazines; Promazine; Promethazine; Radiation Dosage; Thiazines; Thioridazine; Thiothixene; Trifluoperazine; Triflupromazine; Ultraviolet Rays | 1997 |
Inhibitory effect of alkylating modulators on the function of P-glycoprotein.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Breast Neoplasms; Dihydropyridines; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Flupenthixol; Fluphenazine; Humans; Tumor Cells, Cultured; Vinblastine | 1997 |
Depot antipsychotics. Patient characteristics and prescribing pattern.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Clopenthixol; Delayed-Action Preparations; Drug Utilization; Female; Flupenthixol; Fluphenazine; Haloperidol; Hospitals, University; Humans; Male; Middle Aged; Practice Patterns, Physicians'; Psychotic Disorders; Saudi Arabia; Surveys and Questionnaires | 2000 |
Flow and injection characteristics of pharmaceutical parenteral formulations using a micro-capillary rheometer.
Topics: Capillary Action; Chemistry, Pharmaceutical; Flow Injection Analysis; Flupenthixol; Fluphenazine; Haloperidol; Infusions, Parenteral; Medroxyprogesterone Acetate; Rheology; Suspensions; Viscosity | 2004 |
Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Dopamine D2 Receptor Antagonists; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Magnetic Resonance Imaging; Male; Motivation; Neostriatum; Nucleus Accumbens; Olanzapine; Oxygen; Psychomotor Performance; Reaction Time; Receptors, Dopamine D2; Reward; Schizophrenia; Schizophrenic Psychology | 2008 |
Intrathecal chlorprothixene, cis(z)-flupenthixol, chlorpromazine and fluphenazine for prolonged spinal blockades of sensory and motor functions in rats.
Topics: Anesthesia, Spinal; Anesthetics; Animals; Antipsychotic Agents; Behavior, Animal; Chlorpromazine; Chlorprothixene; Dopamine Antagonists; Flupenthixol; Fluphenazine; Injections, Spinal; Male; Nociception; Rats; Rats, Sprague-Dawley; Sensation | 2012 |
Modulating cancer cell survival by targeting intracellular cholesterol transport.
Topics: Administration, Intravenous; Administration, Oral; Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Autophagy; bcl-2-Associated X Protein; Biological Transport; Cell Survival; Cholesterol; Desipramine; Endocytosis; Endosomes; Female; Flupenthixol; Fluphenazine; Gene Expression Regulation; Gene Knockdown Techniques; HCT116 Cells; Homeostasis; Humans; Inhibitory Concentration 50; Liposomes; Lysosomes; MCF-7 Cells; Melanoma; Mice; Nortriptyline; Perphenazine; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Sphingomyelin Phosphodiesterase; STAT3 Transcription Factor | 2017 |
Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Topics: Adenosine Monophosphate; Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chlorpromazine; Clopenthixol; Clozapine; Flupenthixol; Fluphenazine; Haloperidol; Humans; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Pimozide; Quetiapine Fumarate; Risperidone; Sulpiride; Trifluoperazine | 2022 |
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding, Competitive; Blotting, Northern; Brain; Cell Line; Cell Membrane; Cloning, Molecular; Dopamine; Humans; Kinetics; Molecular Sequence Data; Molecular Weight; Oligonucleotide Probes; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D5; RNA, Messenger; Sequence Homology, Nucleic Acid; Transfection | 1991 |
Molecular modeling of phenothiazines and related drugs as multidrug resistance modifiers: a comparative molecular field analysis study.
Topics: Antineoplastic Agents; Cell Survival; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Molecular Conformation; Phenothiazines; Thioxanthenes; Tumor Cells, Cultured | 1998 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Discovery of novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Benzimidazoles; Ciprofloxacin; Databases, Factual; Drug Resistance, Bacterial; Drug Synergism; Ethidium; Microbial Sensitivity Tests; Models, Molecular; Multidrug Resistance-Associated Proteins; Phenyl Ethers; Propanolamines; Quantitative Structure-Activity Relationship; Staphylococcus aureus; Structure-Activity Relationship; Sulfonamides | 2011 |